In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...
Recent estimates show that there are over 2 billion users on Instagram, of which over 726.8 million interact with reels on ...
The trial is designed to assess the safety and effectiveness of Avisi Technologies' investigational VisiPlate device in ...
The combined companies will operate under the name Kalaris Therapeutics, Inc. and expects to report initial data from part 1 ...
The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...
ZEISS VISULAS Combi is an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp ...
The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms.
The company stated that the FDA noted at least one additional adequate and well controlled study to demonstrate a positive ...
Andrew G. Lee, MD, and Drew Carey, MD, return for this episode of 'NeuroOp Guru' to discuss how sixth nerve palsy with ...
The May 4 event, themed around Star Wars, will feature the latest innovations, foster open discussions, and provide a ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Urcosimod (formerly known as OK-101) has been shown to be stable for over 2 and a half years in single-use ampoules used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results